Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $13.07 million. The enterprise value is -$1.13 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.72 million shares outstanding. The number of shares has increased by 1.44% in one year.
| Current Share Class | 35.72M |
| Shares Outstanding | 35.72M |
| Shares Change (YoY) | +1.44% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 19.60% |
| Owned by Institutions (%) | 6.70% |
| Float | 18.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| Forward PS | n/a |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.70 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -88.32% and return on invested capital (ROIC) is -54.87%.
| Return on Equity (ROE) | -88.32% |
| Return on Assets (ROA) | -29.73% |
| Return on Invested Capital (ROIC) | -54.87% |
| Return on Capital Employed (ROCE) | -133.76% |
| Revenue Per Employee | $868,743 |
| Profits Per Employee | -$399,629 |
| Employee Count | 35 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $361,000 in taxes.
| Income Tax | 361,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.60% in the last 52 weeks. The beta is 2.06, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -75.60% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 40.93 |
| Average Volume (20 Days) | 68,193 |
Short Selling Information
The latest short interest is 115,584, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 115,584 |
| Short Previous Month | 142,981 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.63% |
| Short Ratio (days to cover) | 1.38 |
Income Statement
In the last 12 months, Equillium had revenue of $30.41 million and -$13.99 million in losses. Loss per share was -$0.39.
| Revenue | 30.41M |
| Gross Profit | 30.41M |
| Operating Income | -14.35M |
| Pretax Income | -7.81M |
| Net Income | -13.99M |
| EBITDA | -14.21M |
| EBIT | -14.35M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $14.50 million in cash and $295,000 in debt, giving a net cash position of $14.21 million or $0.40 per share.
| Cash & Cash Equivalents | 14.50M |
| Total Debt | 295,000 |
| Net Cash | 14.21M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 10.58M |
| Book Value Per Share | 0.30 |
| Working Capital | 10.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.40 million and capital expenditures -$70,000, giving a free cash flow of -$18.47 million.
| Operating Cash Flow | -18.40M |
| Capital Expenditures | -70,000 |
| Free Cash Flow | -18.47M |
| FCF Per Share | -$0.52 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -47.19% and -46.00%.
| Gross Margin | 100.00% |
| Operating Margin | -47.19% |
| Pretax Margin | -44.81% |
| Profit Margin | -46.00% |
| EBITDA Margin | -46.73% |
| EBIT Margin | -47.19% |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.44% |
| Shareholder Yield | -1.44% |
| Earnings Yield | -106.99% |
| FCF Yield | -141.24% |
Analyst Forecast
The average price target for Equillium is $3.00, which is 719.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.00 |
| Price Target Difference | 719.67% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 17.47% |
| EPS Growth Forecast (5Y) | -22.99% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -13.91 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.91 |
| Piotroski F-Score | 2 |